img

Global Oncology Treatment Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oncology Treatment Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.

When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.

Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.

Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
Oncology Treatment Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oncology Treatment Drug market is projected to reach US$ 342140 million in 2029, increasing from US$ 197440 million in 2022, with the CAGR of 8.0% during the period of 2024 to 2029. Demand from Blood Cancer and Breast Cancer are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oncology Treatment Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Teva
Otsuka
Eisai
Merck KGaA
Gilead Sciences
Segment by Type
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others

Segment by Application


Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Oncology Treatment Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Oncology Treatment Drug introduction, etc. Oncology Treatment Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Oncology Treatment Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Oncology Treatment Drug
1.1 Oncology Treatment Drug Market Overview
1.1.1 Oncology Treatment Drug Product Scope
1.1.2 Oncology Treatment Drug Market Status and Outlook
1.2 Global Oncology Treatment Drug Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Oncology Treatment Drug Market Size by Region (2018-2029)
1.4 Global Oncology Treatment Drug Historic Market Size by Region (2018-2024)
1.5 Global Oncology Treatment Drug Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Oncology Treatment Drug Market Size (2018-2029)
1.6.1 North America Oncology Treatment Drug Market Size (2018-2029)
1.6.2 Europe Oncology Treatment Drug Market Size (2018-2029)
1.6.3 Asia-Pacific Oncology Treatment Drug Market Size (2018-2029)
1.6.4 Latin America Oncology Treatment Drug Market Size (2018-2029)
1.6.5 Middle East & Africa Oncology Treatment Drug Market Size (2018-2029)
2 Oncology Treatment Drug Market by Type
2.1 Introduction
2.1.1 Chemotherapy
2.1.2 Targeted Therapy
2.1.3 Immunotherapy (Biologic Therapy)
2.1.4 Hormonal Therapy
2.1.5 Others
2.2 Global Oncology Treatment Drug Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Oncology Treatment Drug Historic Market Size by Type (2018-2024)
2.2.2 Global Oncology Treatment Drug Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Oncology Treatment Drug Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Oncology Treatment Drug Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Oncology Treatment Drug Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Oncology Treatment Drug Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Oncology Treatment Drug Revenue Breakdown by Type (2018-2029)
3 Oncology Treatment Drug Market Overview by Application
3.1 Introduction
3.1.1 Blood Cancer
3.1.2 Breast Cancer
3.1.3 Gastrointestinal Cancer
3.1.4 Prostate Cancer
3.1.5 Respiratory/Lung Cancer
3.1.6 Others
3.2 Global Oncology Treatment Drug Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Oncology Treatment Drug Historic Market Size by Application (2018-2024)
3.2.2 Global Oncology Treatment Drug Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Oncology Treatment Drug Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Oncology Treatment Drug Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Oncology Treatment Drug Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Oncology Treatment Drug Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Oncology Treatment Drug Revenue Breakdown by Application (2018-2029)
4 Oncology Treatment Drug Competition Analysis by Players
4.1 Global Oncology Treatment Drug Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oncology Treatment Drug as of 2022)
4.3 Date of Key Players Enter into Oncology Treatment Drug Market
4.4 Global Top Players Oncology Treatment Drug Headquarters and Area Served
4.5 Key Players Oncology Treatment Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Oncology Treatment Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Oncology Treatment Drug Products, Services and Solutions
5.1.4 Roche Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.1.5 Roche Recent Developments
5.2 Celgene
5.2.1 Celgene Profile
5.2.2 Celgene Main Business
5.2.3 Celgene Oncology Treatment Drug Products, Services and Solutions
5.2.4 Celgene Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.2.5 Celgene Recent Developments
5.3 Novartis
5.3.1 Novartis Profile
5.3.2 Novartis Main Business
5.3.3 Novartis Oncology Treatment Drug Products, Services and Solutions
5.3.4 Novartis Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.3.5 Bristol-Myers Squibb Recent Developments
5.4 Bristol-Myers Squibb
5.4.1 Bristol-Myers Squibb Profile
5.4.2 Bristol-Myers Squibb Main Business
5.4.3 Bristol-Myers Squibb Oncology Treatment Drug Products, Services and Solutions
5.4.4 Bristol-Myers Squibb Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.4.5 Bristol-Myers Squibb Recent Developments
5.5 Johnson & Johnson
5.5.1 Johnson & Johnson Profile
5.5.2 Johnson & Johnson Main Business
5.5.3 Johnson & Johnson Oncology Treatment Drug Products, Services and Solutions
5.5.4 Johnson & Johnson Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.5.5 Johnson & Johnson Recent Developments
5.6 Merck & Co.
5.6.1 Merck & Co. Profile
5.6.2 Merck & Co. Main Business
5.6.3 Merck & Co. Oncology Treatment Drug Products, Services and Solutions
5.6.4 Merck & Co. Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.6.5 Merck & Co. Recent Developments
5.7 AstraZeneca
5.7.1 AstraZeneca Profile
5.7.2 AstraZeneca Main Business
5.7.3 AstraZeneca Oncology Treatment Drug Products, Services and Solutions
5.7.4 AstraZeneca Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.7.5 AstraZeneca Recent Developments
5.8 Pfizer
5.8.1 Pfizer Profile
5.8.2 Pfizer Main Business
5.8.3 Pfizer Oncology Treatment Drug Products, Services and Solutions
5.8.4 Pfizer Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.8.5 Pfizer Recent Developments
5.9 Amgen
5.9.1 Amgen Profile
5.9.2 Amgen Main Business
5.9.3 Amgen Oncology Treatment Drug Products, Services and Solutions
5.9.4 Amgen Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.9.5 Amgen Recent Developments
5.10 Eli Lilly
5.10.1 Eli Lilly Profile
5.10.2 Eli Lilly Main Business
5.10.3 Eli Lilly Oncology Treatment Drug Products, Services and Solutions
5.10.4 Eli Lilly Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.10.5 Eli Lilly Recent Developments
5.11 AbbVie
5.11.1 AbbVie Profile
5.11.2 AbbVie Main Business
5.11.3 AbbVie Oncology Treatment Drug Products, Services and Solutions
5.11.4 AbbVie Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.11.5 AbbVie Recent Developments
5.12 Takeda
5.12.1 Takeda Profile
5.12.2 Takeda Main Business
5.12.3 Takeda Oncology Treatment Drug Products, Services and Solutions
5.12.4 Takeda Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.12.5 Takeda Recent Developments
5.13 Astellas
5.13.1 Astellas Profile
5.13.2 Astellas Main Business
5.13.3 Astellas Oncology Treatment Drug Products, Services and Solutions
5.13.4 Astellas Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.13.5 Astellas Recent Developments
5.14 Ipsen
5.14.1 Ipsen Profile
5.14.2 Ipsen Main Business
5.14.3 Ipsen Oncology Treatment Drug Products, Services and Solutions
5.14.4 Ipsen Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.14.5 Ipsen Recent Developments
5.15 Sanofi
5.15.1 Sanofi Profile
5.15.2 Sanofi Main Business
5.15.3 Sanofi Oncology Treatment Drug Products, Services and Solutions
5.15.4 Sanofi Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.15.5 Sanofi Recent Developments
5.16 Bayer
5.16.1 Bayer Profile
5.16.2 Bayer Main Business
5.16.3 Bayer Oncology Treatment Drug Products, Services and Solutions
5.16.4 Bayer Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.16.5 Bayer Recent Developments
5.17 Biogen Idec
5.17.1 Biogen Idec Profile
5.17.2 Biogen Idec Main Business
5.17.3 Biogen Idec Oncology Treatment Drug Products, Services and Solutions
5.17.4 Biogen Idec Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.17.5 Biogen Idec Recent Developments
5.18 Teva
5.18.1 Teva Profile
5.18.2 Teva Main Business
5.18.3 Teva Oncology Treatment Drug Products, Services and Solutions
5.18.4 Teva Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.18.5 Teva Recent Developments
5.19 Otsuka
5.19.1 Otsuka Profile
5.19.2 Otsuka Main Business
5.19.3 Otsuka Oncology Treatment Drug Products, Services and Solutions
5.19.4 Otsuka Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.19.5 Otsuka Recent Developments
5.20 Eisai
5.20.1 Eisai Profile
5.20.2 Eisai Main Business
5.20.3 Eisai Oncology Treatment Drug Products, Services and Solutions
5.20.4 Eisai Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.20.5 Eisai Recent Developments
5.21 Merck KGaA
5.21.1 Merck KGaA Profile
5.21.2 Merck KGaA Main Business
5.21.3 Merck KGaA Oncology Treatment Drug Products, Services and Solutions
5.21.4 Merck KGaA Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.21.5 Merck KGaA Recent Developments
5.22 Gilead Sciences
5.22.1 Gilead Sciences Profile
5.22.2 Gilead Sciences Main Business
5.22.3 Gilead Sciences Oncology Treatment Drug Products, Services and Solutions
5.22.4 Gilead Sciences Oncology Treatment Drug Revenue (US$ Million) & (2018-2024)
5.22.5 Gilead Sciences Recent Developments
6 North America
6.1 North America Oncology Treatment Drug Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Oncology Treatment Drug Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Oncology Treatment Drug Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Oncology Treatment Drug Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Oncology Treatment Drug Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Oncology Treatment Drug Market Dynamics
11.1 Oncology Treatment Drug Industry Trends
11.2 Oncology Treatment Drug Market Drivers
11.3 Oncology Treatment Drug Market Challenges
11.4 Oncology Treatment Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Oncology Treatment Drug Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Oncology Treatment Drug Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Oncology Treatment Drug Market Size Share by Region (2018-2024)
Table 4. Global Oncology Treatment Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Oncology Treatment Drug Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Oncology Treatment Drug Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Oncology Treatment Drug Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Oncology Treatment Drug Revenue Market Share by Type (2018-2024)
Table 9. Global Oncology Treatment Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Oncology Treatment Drug Revenue Market Share by Type (2024-2029)
Table 11. North America Oncology Treatment Drug Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Oncology Treatment Drug Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Oncology Treatment Drug Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Oncology Treatment Drug Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Oncology Treatment Drug Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Oncology Treatment Drug Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Oncology Treatment Drug Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Oncology Treatment Drug Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Oncology Treatment Drug Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Oncology Treatment Drug Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Oncology Treatment Drug Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Oncology Treatment Drug Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Oncology Treatment Drug Revenue Market Share by Application (2018-2024)
Table 24. Global Oncology Treatment Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Oncology Treatment Drug Revenue Market Share by Application (2024-2029)
Table 26. North America Oncology Treatment Drug Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Oncology Treatment Drug Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Oncology Treatment Drug Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Oncology Treatment Drug Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Oncology Treatment Drug Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Oncology Treatment Drug Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Oncology Treatment Drug Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Oncology Treatment Drug Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Oncology Treatment Drug Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Oncology Treatment Drug Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Oncology Treatment Drug Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Oncology Treatment Drug Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oncology Treatment Drug as of 2022)
Table 39. Date of Key Players Enter into Oncology Treatment Drug Market
Table 40. Global Oncology Treatment Drug Key Players Headquarters and Area Served
Table 41. Oncology Treatment Drug Product Solution and Service
Table 42. Global Oncology Treatment Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Roche Basic Information List
Table 45. Roche Description and Business Overview
Table 46. Roche Oncology Treatment Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Oncology Treatment Drug Business of Roche (2018-2024)
Table 48. Roche Recent Developments
Table 49. Celgene Basic Information List
Table 50. Celgene Description and Business Overview
Table 51. Celgene Oncology Treatment Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Oncology Treatment Drug Business of Celgene (2018-2024)
Table 53. Celgene Recent Developments
Table 54. Novartis Basic Information List
Table 55. Novartis Description and Business Overview
Table 56. Novartis Oncology Treatment Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Oncology Treatment Drug Business of Novartis (2018-2024)
Table 58. Novartis Recent Developments
Table 59. Bristol-Myers Squibb Basic Information List
Table 60. Bristol-Myers Squibb Description and Business Overview
Table 61. Bristol-Myers Squibb Oncology Treatment Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Oncology Treatment Drug Business of Bristol-Myers Squibb (2018-2024)
Table 63. Bristol-Myers Squibb Recent Developments
Table 64. Johnson & Johnson Basic Information List
Table 65. Johnson & Johnson Description and Business Overview
Table 66. Johnson & Johnson Oncology Treatment Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Oncology Treatment Drug Business of Johnson & Johnson (2018-2024)
Table 68. Johnson & Johnson Recent Developments
Table 69. Merck & Co. Basic Information List
Table 70. Merck & Co. Description and Business Overview
Table 71. Merck & Co. Oncology Treatment Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Oncology Treatment Drug Business of Merck & Co. (2018-2024)
Table 73. Merck & Co. Recent Developments
Table 74. AstraZeneca Basic Information List
Table 75. AstraZeneca Description and Business Overview
Table 76. AstraZeneca Oncology Treatment Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in Oncology Treatment Drug Business of AstraZeneca (2018-2024)
Table 78. AstraZeneca Recent Developments
Table 79. Pfizer Basic Information List
Table 80. Pfizer Description and Business Overview
Table 81. Pfizer Oncology Treatment Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in Oncology Treatment Drug Business of Pfizer (2018-2024)
Table 83. Pfizer Recent Developments
Table 84. Amgen Basic Information List
Table 85. Amgen Description and Business Overview
Table 86. Amgen Oncology Treatment Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in Oncology Treatment Drug Business of Amgen (2018-2024)
Table 88. Amgen Recent Developments
Table 89. Eli Lilly Basic Information List
Table 90. Eli Lilly Description and Business Overview
Table 91. Eli Lilly Oncology Treatment Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in Oncology Treatment Drug Business of Eli Lilly (2018-2024)
Table 93. Eli Lilly Recent Developments
Table 94. AbbVie Basic Information List
Table 95. AbbVie Description and Business Overview
Table 96. AbbVie Oncology Treatment Drug Products, Services and Solutions
Table 97. Revenue (US$ Million) in Oncology Treatment Drug Business of AbbVie (2018-2024)
Table 98. AbbVie Recent Developments
Table 99. Takeda Basic Information List
Table 100. Takeda Description and Business Overview
Table 101. Takeda Oncology Treatment Drug Products, Services and Solutions
Table 102. Revenue (US$ Million) in Oncology Treatment Drug Business of Takeda (2018-2024)
Table 103. Takeda Recent Developments
Table 104. Astellas Basic Information List
Table 105. Astellas Description and Business Overview
Table 106. Astellas Oncology Treatment Drug Products, Services and Solutions
Table 107. Revenue (US$ Million) in Oncology Treatment Drug Business of Astellas (2018-2024)
Table 108. Astellas Recent Developments
Table 109. Ipsen Basic Information List
Table 110. Ipsen Description and Business Overview
Table 111. Ipsen Oncology Treatment Drug Products, Services and Solutions
Table 112. Revenue (US$ Million) in Oncology Treatment Drug Business of Ipsen (2018-2024)
Table 113. Ipsen Recent Developments
Table 114. Sanofi Basic Information List
Table 115. Sanofi Description and Business Overview
Table 116. Sanofi Oncology Treatment Drug Products, Services and Solutions
Table 117. Revenue (US$ Million) in Oncology Treatment Drug Business of Sanofi (2018-2024)
Table 118. Sanofi Recent Developments
Table 119. Bayer Basic Information List
Table 120. Bayer Description and Business Overview
Table 121. Bayer Oncology Treatment Drug Products, Services and Solutions
Table 122. Revenue (US$ Million) in Oncology Treatment Drug Business of Bayer (2018-2024)
Table 123. Bayer Recent Developments
Table 124. Biogen Idec Basic Information List
Table 125. Biogen Idec Description and Business Overview
Table 126. Biogen Idec Oncology Treatment Drug Products, Services and Solutions
Table 127. Revenue (US$ Million) in Oncology Treatment Drug Business of Biogen Idec (2018-2024)
Table 128. Biogen Idec Recent Developments
Table 129. Teva Basic Information List
Table 130. Teva Description and Business Overview
Table 131. Teva Oncology Treatment Drug Products, Services and Solutions
Table 132. Revenue (US$ Million) in Oncology Treatment Drug Business of Teva (2018-2024)
Table 133. Teva Recent Developments
Table 134. Otsuka Basic Information List
Table 135. Otsuka Description and Business Overview
Table 136. Otsuka Oncology Treatment Drug Products, Services and Solutions
Table 137. Revenue (US$ Million) in Oncology Treatment Drug Business of Otsuka (2018-2024)
Table 138. Otsuka Recent Developments
Table 139. Eisai Basic Information List
Table 140. Eisai Description and Business Overview
Table 141. Eisai Oncology Treatment Drug Products, Services and Solutions
Table 142. Revenue (US$ Million) in Oncology Treatment Drug Business of Eisai (2018-2024)
Table 143. Eisai Recent Developments
Table 144. Merck KGaA Basic Information List
Table 145. Merck KGaA Description and Business Overview
Table 146. Merck KGaA Oncology Treatment Drug Products, Services and Solutions
Table 147. Revenue (US$ Million) in Oncology Treatment Drug Business of Merck KGaA (2018-2024)
Table 148. Merck KGaA Recent Developments
Table 149. Gilead Sciences Basic Information List
Table 150. Gilead Sciences Description and Business Overview
Table 151. Gilead Sciences Oncology Treatment Drug Products, Services and Solutions
Table 152. Revenue (US$ Million) in Oncology Treatment Drug Business of Gilead Sciences (2018-2024)
Table 153. Gilead Sciences Recent Developments
Table 154. North America Oncology Treatment Drug Market Size by Country (2018-2024) & (US$ Million)
Table 155. North America Oncology Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 156. Europe Oncology Treatment Drug Market Size by Country (2018-2024) & (US$ Million)
Table 157. Europe Oncology Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 158. Asia-Pacific Oncology Treatment Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 159. Asia-Pacific Oncology Treatment Drug Market Size by Region (2018-2024) & (US$ Million)
Table 160. Asia-Pacific Oncology Treatment Drug Market Size by Region (2024-2029) & (US$ Million)
Table 161. Asia-Pacific Oncology Treatment Drug Market Share by Region (2018-2024)
Table 162. Asia-Pacific Oncology Treatment Drug Market Share by Region (2024-2029)
Table 163. Latin America Oncology Treatment Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 164. Latin America Oncology Treatment Drug Market Size by Country (2018-2024) & (US$ Million)
Table 165. Latin America Oncology Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 166. Middle East & Africa Oncology Treatment Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 167. Middle East & Africa Oncology Treatment Drug Market Size by Country (2018-2024) & (US$ Million)
Table 168. Middle East & Africa Oncology Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 169. Oncology Treatment Drug Market Trends
Table 170. Oncology Treatment Drug Market Drivers
Table 171. Oncology Treatment Drug Market Challenges
Table 172. Oncology Treatment Drug Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Treatment Drug Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Oncology Treatment Drug Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Oncology Treatment Drug Market Share by Regions: 2022 VS 2029
Figure 4. Global Oncology Treatment Drug Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Oncology Treatment Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Oncology Treatment Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Oncology Treatment Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Oncology Treatment Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Oncology Treatment Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Chemotherapy
Figure 11. Global Chemotherapy Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Targeted Therapy
Figure 13. Global Targeted Therapy Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Immunotherapy (Biologic Therapy)
Figure 15. Global Immunotherapy (Biologic Therapy) Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Product Picture of Hormonal Therapy
Figure 17. Global Hormonal Therapy Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 18. Product Picture of Others
Figure 19. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 20. Global Oncology Treatment Drug Market Size Share by Type: 2022 & 2029
Figure 21. North America Oncology Treatment Drug Revenue Market Share by Type (2018-2029)
Figure 22. Europe Oncology Treatment Drug Revenue Market Share by Type (2018-2029)
Figure 23. Asia-Pacific Oncology Treatment Drug Revenue Market Share by Type (2018-2029)
Figure 24. Latin America Oncology Treatment Drug Revenue Market Share by Type (2018-2029)
Figure 25. Middle East and Africa Oncology Treatment Drug Revenue Market Share by Type (2018-2029)
Figure 26. Blood Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 27. Breast Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 28. Gastrointestinal Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 29. Prostate Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 30. Respiratory/Lung Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 31. Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 32. Global Oncology Treatment Drug Market Size Share by Application: 2022 & 2029
Figure 33. North America Oncology Treatment Drug Revenue Market Share by Application (2018-2029)
Figure 34. Europe Oncology Treatment Drug Revenue Market Share by Application (2018-2029)
Figure 35. Asia-Pacific Oncology Treatment Drug Revenue Market Share by Application (2018-2029)
Figure 36. Latin America Oncology Treatment Drug Revenue Market Share by Application (2018-2029)
Figure 37. Middle East and Africa Oncology Treatment Drug Revenue Market Share by Application (2018-2029)
Figure 38. Oncology Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 39. Global Top 5 and Top 10 Players Oncology Treatment Drug Market Share in 2022
Figure 40. North America Oncology Treatment Drug Market Share by Country (2018-2029)
Figure 41. United States Oncology Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 42. Canada Oncology Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 43. Germany Oncology Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 44. France Oncology Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 45. U.K. Oncology Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 46. Italy Oncology Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 47. Russia Oncology Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 48. Nordic Countries Oncology Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 49. Asia-Pacific Oncology Treatment Drug Market Share by Region (2018-2029)
Figure 50. China Oncology Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 51. Japan Oncology Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 52. South Korea Oncology Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 53. Southeast Asia Oncology Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 54. India Oncology Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 55. Australia Oncology Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 56. Latin America Oncology Treatment Drug Market Share by Country (2018-2029)
Figure 57. Mexico Oncology Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 58. Brazil Oncology Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 59. Middle East & Africa Oncology Treatment Drug Market Share by Country (2018-2029)
Figure 60. Turkey Oncology Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 61. Saudi Arabia Oncology Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 62. UAE Oncology Treatment Drug Market Size (2018-2029) & (US$ Million)
Figure 63. Bottom-up and Top-down Approaches for This Report